Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

US Breakthrough Drugs Show No Signs Of Slowing

This article was originally published in SRA

Executive Summary

At least 11 new breakthrough therapy designations have been announced in the first seven weeks of 2016, as the US Food and Drug Administration's expedited review program's popularity continues to rise at a fast pace.